2006
DOI: 10.1016/j.ijpharm.2006.05.004
|View full text |Cite
|
Sign up to set email alerts
|

The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
67
1
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 111 publications
(70 citation statements)
references
References 16 publications
1
67
1
1
Order By: Relevance
“…MFA is a lipophilic molecule. Park and Choi, (2006) reported that the dissolution rate of MFA was substantially enhanced in phosphate buffer medium (pH 6.8) containing CTAB. Figure 5 shows that the drug release rate depends on the concentration of CA in the formulation.…”
Section: In Vitro Releasementioning
confidence: 99%
“…MFA is a lipophilic molecule. Park and Choi, (2006) reported that the dissolution rate of MFA was substantially enhanced in phosphate buffer medium (pH 6.8) containing CTAB. Figure 5 shows that the drug release rate depends on the concentration of CA in the formulation.…”
Section: In Vitro Releasementioning
confidence: 99%
“…Differently, cetyltrimethylammonium bromide (CTAB) did not show the same effect. In general, CTAB, SLS, and polysorbate 80 are common choices for cationic, anionic, and non-ionic surfactants (Table VI) (115).…”
Section: Surfactantsmentioning
confidence: 99%
“…In contrast, the EMA guidance documents (128), WHO Technical Report (2015) (129), and Health Canada (126) require determining the solubility of the highest single dose administered, which in certain cases can be two or more units in 250 mL (115). This shifts many drugs into the Bpoorly soluble^classification category.…”
Section: Regulatory View Of Biopharmaceutics Drug Classification Systmentioning
confidence: 99%
“…e-mail: vagray@rcn.com lar size increases upon addition of an electrolyte to the solution. The type of surfactant determines the effect of ionic strength; for example, the solubility of mefenamic acid is affected by a change in ionic strength when SLS is used but not when CTAB is used (9). In addition, the purity of the surfactant must be considered because it can extensively affect the size and loading capacity of a micelle, which results in changes in solubility and dissolution rate (10,11).…”
Section: Introductionmentioning
confidence: 99%